Market Scorecard
Market Pathways Scorecard: 2025 Roundup
FDA approved a record number of PMA and PMA supplements, and more data on FDA authorizations and global policymaking in 2025 in our latest Scorecard infographic.
Welcome to MyStrategist
Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways
Start Trial
Business Strategies
RebrAIn Update: French AI Company Advances Precision Neurostimulation
David Caumartin, CEO of RebrAIn talked to MedTech Strategist about his company’s progress developing and commercializing a supervised artificial intelligence system that improves the precision of neurosurgery for movement disorders.
Don't Just Advertise... Strategize!
Advertise with MedTech Strategist and be seen by medtech's most influential executives.
Learn More
Pathways’ Pick of the Week
Pathways' Pick of the Week: Medicare Cuts in the Name of Efficiency
CMS trims procedure payments in the name of efficiency. Excerpted from Pathways’ Picks November 5: Medicare Cuts, FDA Panels, China GMP Update, and Global Picks.